Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-01-22 @ 12:04 PM
Study NCT ID:
NCT05355051
Status:
RECRUITING
Last Update Posted:
2025-10-24
First Post:
2022-04-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma
Sponsor:
Organization: